Cancer Res Treat.  2019 Oct;51(4):1632-1638. 10.4143/crt.2019.009.

Feasibility Study of Physician Orders for Life-Sustaining Treatment for Patients with Terminal Cancer

• An HJ
• Jeon HJ
• Chun SH
• Jung HA
• Ahn HK
• Lee KH
• Kim MH
• Kim JH
• Cheon J
• Kim J
• Koh SJ

• KMID: 2460611
• DOI: http://doi.org/10.4143/crt.2019.009

Abstract

PURPOSE
Physician Orders for Life-Sustaining Treatment (POLST) form is a legal document for terminally ill patients to make medical decisions with physicians near the end-of-life. A multicenter prospective study was conducted to evaluate the feasibility of POLST administration in actual oncological practice.
MATERIALS AND METHODS
Patients with terminal cancer, age ≥ 20 years, and capable of communicating were eligible. The primary endpoint was the completion rate of POLST. Data about physicians' or patients' barriers were also collected.
RESULTS
From June to December 2017, 336 patients from seven hospitals were eligible. Median patient age was 66 years (range, 20 to 94 years); 52.7% were male; and 60.4% had poor performance status. Primary cancer sites were hepato-pancreato-biliary (26.2%), lung (23.2%), and gastrointestinal (19.9%). Expected survival duration was 10.6±7.3 weeks, with 41.2% receiving hospice care, 37.9% showing progression after cancer treatment, and the remaining patients were under active treatment (15.8%) or initially diagnosed with terminal cancer (5.1%). POLST forms were introduced to 60.1% of patients, and 31.3% signed the form. Physicians' barriers were reluctance of family (49.7%), lack of rapport (44.8%), patients' denial of prognosis (34.3%), lack of time (22.7%), guilty feelings (21.5%), and uncertainty about either prognosis (21.0%) or the right time to discuss POLST (16.6%). The patients' barriers were the lack of knowledge/understanding of POLST (65.1%), emotional discomfort (63.5%), difficulty in decision-making (66.7%), or denial of prognosis (14.3%).
CONCLUSION
One-third of patients completed POLST forms, and various barriers were identified. To overcome such barriers, social engagement, education, and systematic support might be necessary.

Keyword

Physician Orders for Life-Sustaining Treatment; Terminal cancer; Feasibility

MeSH Terms

Denial (Psychology)
Education
Feasibility Studies*
Hospice Care
Humans
Lung
Male
Prognosis
Prospective Studies
Terminally Ill
Uncertainty

Figure

• 

  Fig. 1. Patients’ diagram. POLST, Physician’s Order for Life-sustaining Treatment.

Reference

References

1. Korean Supreme Court. Withdrawing futile life-sustaining treatment. Seoul: Korean Supreme Court;2009.

2. Ministry of Health and Welfare. Act on hospice and palliative care and decisions on life-sustaining treatment for patients at the end of life. Sejong: Ministry of Health and Welfare;2016.

3. Royal College of Physicians. Advance care planning: concise guideline to good practice, No. 12. London: Royal College of Physicians;2009.

4. Houben CH, Spruit MA, Groenen MT, Wouters EF, Janssen DJ. Efficacy of advance care planning: a systematic review and meta-analysis. J Am Med Dir Assoc. 2014; 15:477–89.

5. Keam B, Yun YH, Heo DS, Park BW, Cho CH, Kim S, et al. The attitudes of Korean cancer patients, family caregivers, oncologists, and members of the general public toward advance directives. Support Care Cancer. 2013; 21:1437–44.

6. Kim S, Hong SW, Kim J. Feasibility of the Korean-advance directives among community-dwelling elderly persons. Holist Nurs Pract. 2017; 31:234–42.

7. Yun YH, Lee CG, Kim SY, Lee SW, Heo DS, Kim JS, et al. The attitudes of cancer patients and their families toward the disclosure of terminal illness. J Clin Oncol. 2004; 22:307–14.

8. Heo DS. Patient autonomy and advance directives in Korea. J Korean Med Assoc. 2009; 52:865–70.

9. Lee JK, Keam B, An AR, Kim TM, Lee SH, Kim DW, et al. Surrogate decision-making in Korean patients with advanced cancer: a longitudinal study. Support Care Cancer. 2013; 21:183–90.

10. Kwon SH, Im SH, Cho KW, Cho E, Yoon SJ, Oh SY. Most advance directives written by patients with advanced cancer or their proxies request only minimally invasive treatments during end-of-life care. Am J Hosp Palliat Care. 2012; 29:622–6.

11. Lee SM, Kim SJ, Choi YS, Heo DS, Baik S, Choi BM, et al. Consensus guidelines for the definition of the end stage of disease and last days of life and criteria for medical judgment. J Korean Med Assoc. 2018; 61:509–21.

12. Alano GJ, Pekmezaris R, Tai JY, Hussain MJ, Jeune J, Louis B, et al. Factors influencing older adults to complete advance directives. Palliat Support Care. 2010; 8:267–75.

13. McDonald JC, du Manoir JM, Kevork N, Le LW, Zimmermann C. Advance directives in patients with advanced cancer receiving active treatment: attitudes, prevalence, and barriers. Support Care Cancer. 2017; 25:523–31.

14. Salmond SW, David E. Attitudes toward advance directives and advance directive completion rates. Orthop Nurs. 2005; 24:117–27.

15. Phipps E, True G, Harris D, Chong U, Tester W, Chavin SI, et al. Approaching the end of life: attitudes, preferences, and behaviors of African-American and white patients and their family caregivers. J Clin Oncol. 2003; 21:549–54.

16. Lammers AJ, Zive DM, Tolle SW, Fromme EK. The oncology specialist's role in POLST form completion. Am J Hosp Palliat Care. 2018; 35:297–303.

17. Tarzian AJ, Cheevers NB. Maryland's medical orders for life-sustaining treatment form use: reports of a statewide survey. J Palliat Med. 2017; 20:939–45.

18. Kong BH, An HJ, Kim HS, Ha SY, Kim IK, Lee JE, et al. Experience of advance directives in a hospice center. J Korean Med Sci. 2015; 30:151–4.

19. Kim S, Koh S, Park K, Kim J. End-of-life care decisions using a Korean advance directive among cancer patient-caregiver dyads. Palliat Support Care. 2017; 15:77–87.

20. You JJ, Downar J, Fowler RA, Lamontagne F, Ma IW, Jayaraman D, et al. Barriers to goals of care discussions with seriously ill hospitalized patients and their families: a multicenter survey of clinicians. JAMA Intern Med. 2015; 175:549–56.

21. Simon J, Porterfield P, Bouchal SR, Heyland D. 'Not yet' and 'Just ask': barriers and facilitators to advance care planning: a qualitative descriptive study of the perspectives of seriously ill, older patients and their families. BMJ Support Palliat Care. 2015; 5:54–62.

22. Travers A, Taylor V. What are the barriers to initiating endof-life conversations with patients in the last year of life? Int J Palliat Nurs. 2016; 22:454–62.

23. De Vleminck A, Pardon K, Beernaert K, Deschepper R, Houttekier D, Van Audenhove C, et al. Barriers to advance care planning in cancer, heart failure and dementia patients: a focus group study on general practitioners' views and experiences. PLoS One. 2014; 9:e84905.

24. Hubert E, Schulte N, Belle S, Gerhardt A, Merx K, Hofmann WK, et al. Cancer patients and advance directives: a survey of patients in a hematology and oncology outpatient clinic. Onkologie. 2013; 36:398–402.

25. Ivo K, Younsuck K, Ho YY, Sang-Yeon S, Seog HD, Hyunah B, et al. A survey of the perspectives of patients who are seriously ill regarding end-of-life decisions in some medical institutions of Korea, China and Japan. J Med Ethics. 2012; 38:310–6.

26. Hagen NA, Howlett J, Sharma NC, Biondo P, Holroyd-Leduc J, Fassbender K, et al. Advance care planning: identifying system-specific barriers and facilitators. Curr Oncol. 2015; 22:e237–45.

27. Kirchhoff KT, Hammes BJ, Kehl KA, Briggs LA, Brown RL. Effect of a disease-specific advance care planning intervention on end-of-life care. J Am Geriatr Soc. 2012; 60:946–50.

28. Lee CH, Lim H, Kim Y, Park AH, Park EC, Kang JG. Analysis of appropriate outpatient consultation time for clinical departments. Health Policy Manag. 2014; 24:254–60.

29. Back AL, Arnold RM, Baile WF, Fryer-Edwards KA, Alexander SC, Barley GE, et al. Efficacy of communication skills training for giving bad news and discussing transitions to palliative care. Arch Intern Med. 2007; 167:453–60.

30. Butler M, Ratner E, McCreedy E, Shippee N, Kane RL. Decision aids for advance care planning: an overview of the state of the science. Ann Intern Med. 2014; 161:408–18.